Simplex Trading’s Trillium Therapeutics Inc. TRIL Stock Holding History

Simplex Trading’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-6,800	Closed	-$67K	–	11969
2021 Q3	$67K	Hold	6,800	–	–	﹤0.01%	7159
2021 Q2	$65K	Buy	6,800 +6,491	+2,101%	+$61.1K	﹤0.01%	7327
2021 Q1	$331K	Buy	+309	New	+$3.82K	﹤0.01%	4021
2020 Q4	–	Sell	-319	Closed	-$453K	–	9396
2020 Q3	$453K	Buy	+319	New	+$3.18K	﹤0.01%	3126
2020 Q2	–	Sell	-50	Closed	-$20K	–	8699
2020 Q1	$20K	Buy	+50	New	+$189	﹤0.01%	5980
2018 Q3	–	Sell	-10	Closed	-$6K	–	8356
2018 Q2	$6K	Buy	+10	New	+$64	﹤0.01%	6656
2018 Q1	–	Sell	-11	Closed	-$2K	–	7169
2017 Q4	$2K	Buy	+11	New	+$91	﹤0.01%	5326

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Simplex Trading's TRIL Position: Q2 2021 in Review

Simplex Trading sold out of Trillium Therapeutics Inc. (TRIL) in Q2 2021, closing a stake of 41,948 shares — an estimated $395K sold.

Simplex Trading first reported a position in TRIL in Q2 2018 and held it in 5 quarters. The position peaked at $450K in Q1 2021. 137 funds tracked by Wall St. Rank hold TRIL as of Q2 2021.

Simplex Trading reported no remaining Trillium Therapeutics Inc. position as of Q2 2021 after selling out during the quarter.
Simplex Trading sold 41,948 Trillium Therapeutics Inc. shares in Q2 2021, an estimated $395K.
Simplex Trading first reported a position in Trillium Therapeutics Inc. in Q2 2018 and held it in 5 quarters.
Simplex Trading's Trillium Therapeutics Inc. position peaked at $450K in Q1 2021.
137 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q2 2021.

Based on Simplex Trading's 13F filing for Q2 2021, filed 12 Aug 2021.